1x7t

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1x7t.gif|left|200px]]
[[Image:1x7t.gif|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1x7t |SIZE=350|CAPTION= <scene name='initialview01'>1x7t</scene>, resolution 1.6&Aring;
+
The line below this paragraph, containing "STRUCTURE_1x7t", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND=
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE= TTR, PALB ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 Homo sapiens])
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1x7t| PDB=1x7t | SCENE= }}
-
|RELATEDENTRY=[[1x7s|1X7S]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1x7t FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1x7t OCA], [http://www.ebi.ac.uk/pdbsum/1x7t PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1x7t RCSB]</span>
+
-
}}
+
'''Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects'''
'''Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects'''
Line 31: Line 28:
[[Category: Pereira, P J.B.]]
[[Category: Pereira, P J.B.]]
[[Category: Saraiva, M J.]]
[[Category: Saraiva, M J.]]
-
[[Category: amyloid]]
+
[[Category: Amyloid]]
-
[[Category: familial amyloidotic polyneuropathy]]
+
[[Category: Familial amyloidotic polyneuropathy]]
-
[[Category: transthyretin]]
+
[[Category: Transthyretin]]
-
[[Category: x-ray crystallography]]
+
[[Category: X-ray crystallography]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 14:40:41 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Mar 31 00:45:53 2008''
+

Revision as of 11:40, 3 May 2008

Template:STRUCTURE 1x7t

Structure of TTR R104H: a non-amyloidogenic variant with protective clinical effects


Overview

Transthyretin (TTR) is a homotetrameric plasma protein that, as a result of a set of not yet fully characterized conformational changes, forms fibrillar aggregates that are the major protein component of amyloid deposits. More than 80 mutations associated with TTR amyloid deposition have been described in the literature. X-ray crystallography was used to elucidate the three-dimensional structure of two important TTR variants: TTR Y78F, an amyloidogenic protein, and TTR R104H, which is associated with a protective effect over the amyloidogenic V30M mutation. The structures of those two TTR variants have been determined in space group P2(1)2(1)2 to 1.55 and 1.60 angstroms resolution, respectively, using molecular-replacement techniques. Detailed analysis of the protein model for TTR Y78F indicates a destabilization of the contacts between the alpha-helix and AB loop and the body of the molecule, intimately related to the amyloidogenic nature; contrastingly, in the TTR R104H variant new contacts involving the N-terminal region and His104 are clearly antagonists of amyloid formation.

About this Structure

1X7T is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

X-ray crystallographic studies of two transthyretin variants: further insights into amyloidogenesis., Neto-Silva RM, Macedo-Ribeiro S, Pereira PJ, Coll M, Saraiva MJ, Damas AM, Acta Crystallogr D Biol Crystallogr. 2005 Mar;61(Pt 3):333-9. Epub 2005, Feb 24. PMID:15735344 Page seeded by OCA on Sat May 3 14:40:41 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools